Ruth E. Langley

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Transdermal Estradiol Patches in Prostate Cancer. Reply.

Transdermal Estradiol Patches in Prostate Cancer. Reply.

Journal: The New England journal of medicine

Published: July 29, 2026

Authors' Reply: "Healthcare Systems Data to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of Healthcare Systems Data and Trial-reported Outcomes Within the Add-Aspirin Cancer Clinical Trial".

Authors' Reply: "Healthcare Systems Data to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of Healthcare Systems Data and Trial-reported Outcomes Within the Add-Aspirin Cancer Clinical Trial".

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 08, 2026

The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.

The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 13, 2026

The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

Journal: British journal of cancer

Published: April 02, 2026

Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials.

Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials.

Journal: ESMO open

Published: March 31, 2026

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.

Journal: The New England journal of medicine

Published: March 25, 2026

Impact of ETI therapy on bone health, body composition and cardiopulmonary fitness in children with CF.

Impact of ETI therapy on bone health, body composition and cardiopulmonary fitness in children with CF.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 03, 2026

Understanding How Aspirin Prevents Metastasis.

Understanding How Aspirin Prevents Metastasis.

Journal: The New England journal of medicine

Published: December 10, 2025

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 07, 2025

On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.

On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.

Journal: The Lancet. Oncology

Published: November 05, 2025

Preferences between three options for androgen deprivation therapy: a focus group study.

Preferences between three options for androgen deprivation therapy: a focus group study.

Journal: BJU international

Published: July 31, 2025

Suspending the NHS medicines repurposing programme in England is a missed opportunity.

Suspending the NHS medicines repurposing programme in England is a missed opportunity.

Journal: BMJ (Clinical research ed.)

Published: July 02, 2025

Showing 1-12 of 122

Last Updated: 09/26/2026